Weight loss drugs allegedly landed this woman in the hospital. She's suing.
Do weight loss drug labels warn enough about potential side effects? A patient who needed emergency surgery is suing prescription drugmaker Novo Nordisk.
Wegovy
Prices slashed on weight-loss drug Zepbound
Eli Lilly is slashing prices for certain doses of its weight loss drug Zepbound, selling single-dose vials at much cheaper prices for people who pay out of pocket. Dr. Timothy Mackey, professor in the Global Health Program at the University of California, San Diego, joined CBS News to discuss the price cuts.
Examining study on weight loss drugs and suicide
A new study found a link between popular weight loss drugs and suicidal thoughts, but there are questions about the scope and method of the study. Dr. Jonathan LaPook explains what to make of the findings.
Skepticism over study into weight loss drugs
Several doctors say the findings of a new study linking popular new weight loss drugs to the risk of suicide should be taken with a grain of salt. CBS News chief medical correspondent Dr. Jon LaPook has more.
Can weight loss drugs curb more than appetite?
CBS News chief medical correspondent Dr. Jon LaPook takes a look at new research that suggests popular drugs like Ozempic and Wegovy might help with other cravings.
Could weight loss drugs curb other addictions?
A group of weight loss and diabetes treatment drugs, known as GLP-1 agonists, work by curbing appetite centers in the brain. But animal studies suggest these drugs could also potentially reduce addiction to nicotine, alcohol, and opioids. Dr. Jon LaPook explains.
Why millions are trying FDA-approved alternatives to Big Pharma's weight loss drugs
Novo Nordisk and Lilly can't keep up with demand for their weight loss drugs such as Ozempic, Wegovy and Mounjaro. But they object to specialty pharmacies making their own cheaper versions to fill the gap — providing as much as 30% of those drugs sold in the U.S.
Ozempic craze can trigger complicated feelings for those who wished for "magic fix"
Even if someone has gone through a healing process with body image or their relationship with food, these challenges can "last a lifetime," a licensed mental health counselor tells CBS News.
Are enough doctors trained on obesity drugs?
As weight loss drugs like Ozempic and Wegovy become more popular, obesity medicine specialists are concerned that not enough physicians have received specialized training to help patients navigate the medicine. Dr. Celine Gounder, CBS News medical contributor and editor-at-large for public health at KFF, has more on the situation.
Nestle to launch food products that cater to Wegovy and Ozempic users
Vital Pursuit will include whole-grain bowls, protein pasta, sandwich melts and gluten-free options.
Hims & Hers to sell GLP-1 weight loss drug for 85% less than Wegovy
Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.
Cost of diabetes, obesity drugs often out of reach for low-income patients
While it may seem like everyone is taking Ozempic, not everyone can afford to. The high price of popular diabetes drugs prevents many people from getting them.
Scams on TikTok targeting weight loss drugs
A joint investigation by Digital Citizens Alliance and Coalition for a Safer Web found dozens of TikTok profiles offering to ship weight loss drugs for lower prices and without a prescription. In nearly every situation, it was a scam.
Using weight-loss drugs before pregnancy
Doctors are seeing more women turn to weight-loss drugs ahead of pregnancy. Studies show that being overweight can increase the chances of pregnancy complications, including miscarriages. And while the FDA does not authorize the use of weight loss medications during pregnancy, there is limited information on their effects before conception. Dr. Ilana Ramer Bass, an assistant professor in the division of endocrinology, diabetes and metabolism at Mount Sinai, joined CBS News to discuss the trend.
Doctors hopeful Ozempic, Wegovy may help treat alcohol addiction
Several clinical trials are underway to see if semaglutide, the active ingredient in weight loss drugs like Wegovy and Ozempic, can also help treat alcohol addiction.
Can Ozempic and Wegovy curb alcohol cravings?
Doctors are seeing a surprising possible side effect of weight loss drugs like Ozempic and Wegovy: a diminished craving for alcohol. Janet Shamlian reports.
New study on weight loss drug Wegovy
A new study published in the The New England Journal of Medicine by the maker of the popular weight loss drug Wegovy finds the medication could lower the risk of serious and even deadly heart problems by 20%. CBS News chief medical correspondent Dr. Jon LaPook joins "CBS Mornings" to discuss.
Possible Ozempic side effects, including hair loss, probed by FDA
Ozempic and other GLP-1 RA drugs, including Wegovy, Mounjaro and Zepbound, are being scrutinized.
WeightWatchers launches program for weight-loss drug users
WeightWatchers program aims to help members maintain healthy habits while taking anti-obesity drugs like Ozempic and Wegovy.
Poison centers see spike weight-loss drug calls
America's Poison Centers, a group that represents poison control centers across the U.S., reported a major spike in calls this year related to semaglutide, the main ingredient in weight loss drugs such as Ozempic and Wegovy.
Black patients have less access to anti-obesity drugs, data shows
According to data, while Black people are much more likely to suffer from obesity and diabetes, white people are four times more likely to get a prescription.
Doctors see demand for weight-loss drugs
Doctors across the country are dealing with soaring demand for injectable weight-loss drugs, especially among people who are not clinically obese. Drugs like Ozempic and Wegovy have proved to be especially effective for weight loss, but some health experts are worried their increased use could potentially be harmful to certain patients. Dr. Shauna Levy, medical director of Tulane's Bariatric and Weight Loss Center, joined CBS News to discuss the medications.
Wegovy weight-loss drug cut serious heart risk by 20%, study finds
A new study from drugmaker Novo Nordisk found that its weight-loss drug Wegovy can reduce the risk of heart problems in people without diabetes, which could change the way doctors treat certain heart patients.
FDA approves new weight loss drug Zepbound
The FDA has approved a new drug from Eli Lilly to help Americans lose weight: Zepbound. The drug is a new formula of the popular diabetes treatment Mounjaro and it joins other medications like Ozempic and Wegovy as weapons against obesity. Emergency medicine physician Dr. Owais Durrani joined CBS News to discuss the new drug and its potential side effects.
FDA investigating reports of hospitalizations after fake Ozempic
It is unclear if the counterfeit drugs, which many people seek for weight loss, caused the hospitalizations.
Live
3 children, 1 teacher killed in Oregon school shooting, police say
Exclusive
Ousted general warned of missile defense shortage before Iran war
Trump calls off plan to livestream Fort Hood shooter's execution
Live
Strait of Hormuz still unsafe for ships, maritime group warns
White House prepares plans to use "mother of all bombs" on Iran
Vance says "selling access to the White House" is "disgusting"
White House's Katie Zacharia confirms she never passed bar exam
Sikh separatist says FBI warned him of new threat against him
